With the talk surrounding vaccine hesitancy in people — along with outbreaks of measles, mumps and whooping cough — I’m wondering what vaccines are really needed in dogs. My dog was going to the vet ...
With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...
About 1 in 6 parents in the U.S. have skipped or delayed vaccinating their kids against diseases other than COVID or the flu. Now those same fears over vaccine safety are spreading to pet owners.
As bird flu cases steadily rise in Pennsylvania, especially in Lancaster County, U.S. Rep. Lloyd Smucker says he wants the county to serve as a testing ground for a potential vaccine. More than 7.7 ...
Moderna said the Food and Drug Administration has agreed to review its experimental mRNA flu shot, reversing an earlier decision to refuse to accept the application. The FDA is slated to make a ...
Shares of Moderna surged Wednesday after the drugmaker got health regulators to change their minds and start reviewing the biotechnology company’s flu-vaccine candidate for potential approval. The ...
The Food and Drug Administration has reversed its shocking refusal to consider Moderna’s mRNA flu vaccine for approval. The refusal was revealed last week in a sharply worded press release from ...
The U.S. Food and Drug Administration is cancelling development of a new flu vaccine from biotech giant Moderna, with one unnamed senior FDA official calling the clinical trial a “brazen failure.” In ...
Matthew Herper covers medical innovation — both its promise and its perils. Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...
The U.S. will participate in the World Health Organization’s (WHO) upcoming meeting on the composition of the influenza vaccine despite officially withdrawing from the global group last month. The WHO ...
Federal officials on Wednesday cast blame on Moderna as they stood by the Food and Drug Administration’s controversial decision not to review the Cambridge biotech’s new flu vaccine. In a press ...